稳定期慢性阻塞性肺疾病患者报告结局现状及影响因素分析

doi:10.3761/j.issn.0254-1769.2022.01.004

摘要/Abstract

摘要：

目的了解稳定期慢性阻塞性肺疾病 (chronic obstructive pulmonary disease,COPD) 患者报告结局现状,分析其影响因素及与炎症指标的相关性,为开展以患者为中心的早期护理干预提供依据。方法采用便利抽样法,选取2020年10月—2021年7月于南宁市某三级甲等医院呼吸内科门诊就诊的稳定期COPD患者作为调查对象,采用一般资料调查表、COPD患者报告结局量表修订版 (the Modified Patient-Reported Outcome Scale for COPD,mCOPD-PRO) 进行调查,并收集患者就诊时炎症指标的结果。采用多元线性回归分析稳定期COPD患者报告结局的影响因素,采用相关性分析探讨患者报告结局与炎症指标的关系。结果该研究共纳入204例稳定期COPD患者,mCOPD-PRO得分为 (1.75±0.58) 分。多元线性回归分析显示,性别、合并疾病数量、病程、肺功能分级是稳定期COPD患者报告结局的影响因素 (P<0.05),可解释稳定期COPD患者报告结局10.8%的总变异。相关性分析显示,白细胞计数、中性粒细胞计数、嗜酸性粒细胞计数与稳定期COPD患者的mCOPD-PRO得分呈正相关 (P<0.05) ;总白蛋白浓度与其呈负相关 (P<0.05) 。结论稳定期COPD患者报告结局有待改善,女性、合并疾病数量>3种、病程较长、肺功能分级较高的COPD患者报告的结局较差。COPD患者报告结局与白细胞计数、中性粒细胞计数、嗜酸性粒细胞计数、总白蛋白浓度相关。护理人员应关注稳定期COPD患者报告结局及炎症指标,在早期采取针对性的干预措施,以改善患者的生活质量。

关键词: 肺疾病,慢性阻塞性, 患者报告结局, 炎症, 影响因素分析, 护理

Abstract:

Objective To analyze the influencing factors of patient reported outcomes in patients with stable chronic obstructive pulmonary disease (COPD) and the correlation with inflammatory indexes,so as to provide the reference for the early nursing intervention with the focus of patients. Methods The convenience sampling method was used to select outpatients with stable COPD from the department of respiratory clinic of a tertiary hospital in Nanning from October 2020 to July 2021. Questionnaires,including a general information questionnaire and the revised version of the Chronic Obstructive Pulmonary Disease Patient Reported Outcome Scale (mCOPD-PRO),were used to collect the results of inflammatory response indicators at the time. Results A total of 204 patients with stable COPD were included,with the mCOPD-PRO score of (1.75±0.58). Multiple regression analysis showed that the factors influencing the patient reported outcomes with stable COPD were gender,the number of comorbidities,disease duration,and lung function grading (P<0.05),which explained 10.8 % of the variance. There were positive correlations between patient reported outcomes with stable COPD and white blood cell count (WBC),neutrophil count (NEU),and eosinophil count (EOS) (P<0.05). There were negative correlations between patient reported outcomes with stable COPD and total albumin (TP) (P<0.05). Conclusion The health level of patients reported outcomes in stable COPD needs to be improved. Female patients,patients with comorbidities>3,longer duration and worse lung function reported lower levels of health. Patient reported outcomes with COPD are closely related to the levels of serum WBC,NEU,EOS and TP. Medical staff should pay more attention to patients reported outcomes and inflammatory indexes in stable COPD,and take targeted intervention measures in the early stage to improve the quality of life of patients.

Key words: Pulmonary Disease,Chronic Obstructive, Patients Reported Outcomes, Inflammation, Root Cause Analysis, Nursing Care

蔡梦骞, 崔妙玲, 农荧, 覃金莲, 莫素猜, 杨珍娇. 稳定期慢性阻塞性肺疾病患者报告结局现状及影响因素分析[J]. 中华护理杂志, 2022, 57(1): 29-35.

CAI Mengqian, CUI Miaoling, NONG Ying, QIN Jinlian, MO Sucai, YANG Zhenjiao. The current status of patient reported outcomes and its influencing factors in patients with stable chronic obstructive pulmonary disease[J]. Chinese Journal of Nursing, 2022, 57(1): 29-35.

图/表 4

表1 稳定期慢性阻塞性肺疾病患者一般资料及患者报告结局的单因素分析结果 (n=204)

Table 1 The general data of patients with stable chronic obstructive pulmonary disease and univariate analysis analysis results of patient-reported outcomes (n=204)

表2 自变量赋值方式

Table 2 Variables assignment table

表3 稳定期慢性阻塞性肺疾病患者报告结局的多元线性回归分析结果 (n=204)

Table 3 Multiple regression analysis results of patient-reported outcomes in stable chronic obstructive pulmo-nary disease (n=204)

表4 稳定期慢性阻塞性肺疾病患者报告结局与炎症指标的相关性分析 (n=204)

Table 4 Correlation between patient reported outcomes and inflammatory indexes in stable chronic obstructive pulmonary disease (n=204)

参考文献 34

[1]	GBD DALYs, and HALE Collaborators. Global,regional,and national disability-adjusted life-years(DALYs) for 359 diseases and injuries and healthy life expectancy(HALE) for 195 countries and territories,1990-2017:a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2018, 392(10159):1859-1922. DOI URL
[2]	WHO. Projections of mortality and causes of death,2016 and 2060[EB/OL].(2019-10-14)[2021-09-27]. https://www.who.inthealthinfo/global_burden_disease/projections/en/.
[3]	Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH] study):a national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717. DOI URL
[4]	Ejiofor SI, Stolk J, Fernandez P, et al. Patterns and characterization of COPD exacerbations using real-time data collection[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12:427-434. DOI URL
[5]	Carvalho-Jr LCS, Trimer R, Arêas GP, et al. COPD assessment test and FEV₁:do they predict oxygen uptake in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13:3149-3156. DOI URL
[6]	US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry:patient-reported outcome measures:use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcomes, 2006, 4:79. DOI URL
[7]	Kluetz PG, O’Connor DJ, Soltys K. Incorporating the patient experience into regulatory decision making in the USA,Europe,and Canada[J]. Lancet Oncol, 2018, 19(5):e267-e274. DOI URL
[8]	Global Initiative for Chronic Lung Disease (GOLD) . Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease 2020 report[EB/OL]. (2019-11-05) [2021-10-06]. https://goldCOPD.org/gold-reports/.
[9]	杨苏, 黄丽华. 患者自我报告结局在慢性阻塞性肺疾病患者中的应用进展[J]. 中华护理杂志, 2020, 55(5):716-720.
	Yang S, Huang LH. Progress on the application of self-reported outcome measures in patients with chronic obstructive pulmonary disease[J]. Chin J Nurs, 2020, 55(5):716-720.
[10]	倪平, 陈京立, 刘娜. 护理研究中量性研究的样本量估计[J]. 中华护理杂志, 2010, 45(4):378-380.
	Ni P, Chen JL, Liu N. The sample size estimation in quantitative nursing research[J]. Chin J Nurs, 2010, 45(4):378-380.
[11]	Li JS, Wang JJ, Xie Y, et al. Development and validation of the Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease(mCOPD-PRO)[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15:661-669. DOI URL
[12]	Lim KE, Kim SR, Kim HK, et al. Symptom clusters and quality of life in subjects with COPD[J]. Respir Care, 2017, 62(9):1203-1211. DOI URL
[13]	Trivedi D. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease[J]. Prim Health Care Res Dev, 2020, 21:e41. DOI URL
[14]	Hodson M, Roberts CM, Andrew S, et al. Development and first validation of a patient-reported experience measure in chronic obstructive pulmonary disease(PREM-C9)[J]. Thorax, 2019, 74(6):600-603. DOI URL
[15]	Ekström M, Sundh J, Larsson K. Patient reported outcome measures in chronic obstructive pulmonary disease:which to use[J]. Expert Rev Respir Med, 2016, 10(3):351-362. DOI URL
[16]	Han MK. Chronic obstructive pulmonary disease in women:a biologically focused review with a systematic search strategy[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15:711-721. DOI URL
[17]	Christensen VL, Rustøen T, Cooper BA, et al. Distinct symptom experiences in subgroups of patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:1801-1809. DOI URL
[18]	刘林霞, 曾玉琴, 刘祁汨, 等. 女性慢性阻塞性肺疾病的临床特点[J]. 中国医师杂志, 2020, 22(10):1461-1463,1467.
	Liu LX, Zeng YQ, Liu QM, et al. Clinical features of chronic obstructive pulmonary disease in women[J]. J Chin Physician, 2020, 22(10):1461-1463,1467.
[19]	Perez TA, Castillo EG, Ancochea J, et al. Sex differences between women and men with COPD:a new analysis of the 3CIA study[J]. Respir Med, 2020, 171:106105.
[20]	Gut-Gobert C, Cavaillès A, Dixmier A, et al. Women and COPD:do we need more evidence[J]. Eur Respir Rev, 2019, 28(151):180055.
[21]	张倩, 李晶华, 马天娇, 等. Charlson合并症指数对COPD患者住院时间、住院费用及院内死亡的影响[J]. 医学与社会, 2021, 34(8):73-78.
	Zhang Q, Li JH, Ma TJ, et al. The influence of Charlson comorbidity index on length of stay,cost of hospitalization and in-hospital death in patients with COPD[J]. Med Soc, 2021, 34(8):73-78.
[22]	Frent SM, Chapman KR, Larbig M, et al. Capturing exacerbations of chronic obstructive pulmonary disease with EXACT. A subanalysis of FLAME[J]. Am J Respir Crit Care Med, 2019, 199(1):43-51. DOI URL
[23]	娄正磊, 袁茹. 老年慢性阻塞性肺疾病患者心理社会适应水平及影响因素[J]. 中国健康心理学杂志, 2021, 29(6):835-838.
	Lou ZL, Yuan R. Psychosocial adaptation level and its influencing factors of elderly patients with COPD[J]. China J Heal Psychol, 2021, 29(6):835-838.
[24]	Jones PW, Donohue JF, Nedelman J, et al. Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease:a pooled analysis[J]. Respir Res, 2011, 12:161. DOI URL
[25]	Donohue JF, Jones PW, Bartels C, et al. Correlations between FEV₁ and patient-reported outcomes:a pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease[J]. Pulm Pharmacol Ther, 2018, 49:11-19. DOI PMID
[26]	张义静, 李娟, 孙丽, 等. 慢性阻塞性肺疾病患者早期简易肺康复方案的构建及应用[J]. 中华护理杂志, 2020, 55(5):690-695.
	Zhang YJ, Li J, Sun L, et al. Construction of an early simple pulmonary rehabilitation program for patients with COPD and its evaluation of effectiveness[J]. Chin J Nurs, 2020, 55(5):690-695.
[27]	胡磊, 张大卫, 江浩洋, 等. 慢性阻塞性肺疾病患者系统性炎症水平与肺气肿程度和骨密度改变相关性研究[J]. 中华结核和呼吸杂志, 2021, 44(3):213-217.
	Hu L, Zhang DW, Jiang HY, et al. Correlation between systemic inflammation level and emphysema degree and bone mineral density in chronic obstructive pulmonary disease patients and its mechanism[J]. Chin J Tuberc Respir Dis, 2021, 44(3):213-217.
[28]	Tian W, Jiang XG, Kim D, et al. Leukotrienes in tumor-associated inflammation[J]. Front Pharmacol, 2020, 11:1289. DOI PMID
[29]	McKeever TM, Hearson G, Housley G, et al. Using venous blood gas analysis in the assessment of COPD exacerbations:a prospective cohort study[J]. Thorax, 2016, 71(3):210-215. DOI PMID
[30]	Müllerová H, Hahn B, Simard EP, et al. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:683-692. DOI URL
[31]	Wright TK, Gibson PG, Simpson JL, et al. Neutrophil extracellular traps are associated with inflammation in chronic airway disease[J]. Respirology, 2016, 21(3):467-475. DOI URL
[32]	王赛男. 血清白蛋白与球蛋白比值在慢性阻塞性肺疾病急性加重患者中的临床意义[D]. 郑州:郑州大学, 2020.
	Wang SN. Clinical significance of serum albumin to globulin ratio in patients with acute exacerbation of chronic obstructive pulmonary disease[D]. Zhengzhou:Zhengzhou University, 2020.
[33]	Upadhyay K, Uniyal A, Guleria R, et al. Serum prealbumin is a useful marker of inflammation and monitoring tool in patients with AECOPD[J]. Chest, 2013, 144(4):88.
[34]	谢梅, 刘春红, 刘艳琴. 老年慢性阻塞性肺疾病住院病人的营养水平及肺功能分析[J]. 实用老年医学, 2019, 33(10):1012-1015.
	Xie M, Liu CH, Liu YQ. Nutritional status and lung function in elderly inpatients with chronic obstructive pulmonary disease[J]. Pract Geriatr, 2019, 33(10):1012-1015.